Award
National Institute on Aging 3R01AG087158-03S1
Testing effects of cash transfers on biological aging and risk for Alzheimer's Disease
Recipient
Columbia University Health Sciences
Award Amount
$279,470.00
Ceiling
$279,470.00
Awarded
March 06, 2026
Identifier
3R01AG087158-03S1
A study funded by the National Institute on Aging to evaluate the impact of cash transfer programs on biological aging and Alzheimer's Disease risk through epigenetic and immune aging analyses in a randomized trial with 4,000 participants in low-resource settings.
Description
This project aims to assess the effects of cash transfer programs on biological aging and dementia risk using epigenetic clock analysis and immune aging measures. It involves a randomized controlled trial with 4,000 participants in low-resource settings, including Malawi and South Africa, to test if cash transfers can slow biological aging and reduce Alzheimer's Disease risk.